Annual Drug Patent Expirations for RAPIVAB
Rapivab is a drug marketed by Biocryst and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
This drug has sixty-seven patent family members in twenty-eight countries.
The generic ingredient in RAPIVAB is peramivir. One supplier is listed for this compound. Additional details are available on the peramivir profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
